Oct 13, 2020 / 08:30PM GMT
Operator
Greetings and welcome to Eyenovia Corporate Update Conference Call. (Operator Instructions) Please note, this conference is being recorded.
I would now like to turn the conference over to your host, Eric Ribner, Investor Relations. Thank you. You may begin.
Eric Ribner - LifeSci Advisors - Managing Director
Good afternoon and welcome to Eyenovia's conference call to discuss the company's exclusive license agreement with Bausch + Lomb, and both companies -- that both companies announced yesterday, along with Eyenovia's other recent business development activities.
With me today are Dr. Sean Ianchulev, Eyenovia's Chief Executive Officer and Chief Medical Officer; Michael Rowe, Eyenovia's Vice President of Commercial; and John Gandolfo, Eyenovia's Chief Financial Officer.
Except for historical information, all of the statements, expectations and assumptions contained in this conference call are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs,
Eyenovia, Inc. - Special Call Transcript
Oct 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers